Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest TB Stories

2012-04-09 09:50:27

Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE). Currently, TB is diagnosed through either a skin test, which produces a small bump on the patient's arm when administered...

2012-04-04 23:02:48

For decades, fans of The Chronicles of Narnia have been drawn into the pages of “The Space Trilogy”–now, E-book readers are invited to experience Lewis´ magical vision of other-worldly creatures and heroic adventures. San Francisco, CA (PRWEB) April 04, 2012 HarperOne, in collaboration with the estate of C. S. Lewis, announces the first English language E-book release of his three classic “Space Trilogy” titles–Out of the Silent Planet, Perelandra,...

2012-04-02 09:12:31

Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care (ESTC). The 21 patient-centered standards aim to guide clinicians and public health workers to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe — with nearly 74,000 reported TB cases in the EU/EEA in 2010 clearly showing that TB remains a public health challenge...

2012-03-27 08:34:42

A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) – a disease that kills 2 million people annually – a scientist reported today at the 243 National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the U.S. Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics. ACS, the world's...

2012-03-27 02:27:31

FRANKLIN LAKES, N.J., March 27, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and FIND (Foundation for Innovative New Diagnostics) have announced a new collaboration to promote access to early and accurate diagnosis of multidrug-resistant tuberculosis (MDR-TB) among HIV-infected patients and other vulnerable populations in India, a country that accounts for nearly 25 percent of TB cases globally. The 18-month program will focus on increasing the number of accurately...

2012-03-25 23:01:47

Looking at the current state of TB knowlege and new cases we have come a long way, but dont think that this is over. Cleveland, OH (PRWEB) March 24, 2012 Consequences of Underfunding TB "Looking at the current state of TB knowledge and new cases we have come a long way, but don't think that this is over," says Alex Frankel director of whatistbweb.com. "We really believe that the internet has allowed us to cover more ground quickly and get the message out." Decline in burden of TB "In many...

2012-03-21 05:45:41

(Ivanhoe Newswire) — New, more effective vaccines will be decisive in the fight against TB. More than 10 million children have been orphaned by the disease, which is rapidly becoming resistant to available treatment options. Top scientific experts, all over the world, are working together to develop a vaccine that will eliminate TB on all fronts and levels. To address the many challenges posed by TB, ideal vaccine regimens must protect babies at birth from childhood TB, and prevent...

2012-03-20 06:26:14

WASHINGTON, March 20, 2012 /PRNewswire-USNewswire/ -- Today, the U.S. Agency for International Development (USAID) released its annual report to Congress on U.S. Government (USG) international foreign assistance for tuberculosis (TB) control. The report documents the significant progress that has been made toward Global Health Initiative (GHI) TB targets through sustained and well-focused investments. The USG, in partnership with developing country National TB Control...

2012-03-20 11:25:48

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and...

2012-03-20 11:24:28

Field-wide effort builds consensus for path forward Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis, the strategic blueprint for the TB vaccine field represents consensus reached by the TB vaccine community. “The TB Vaccine Blueprint...